Literature DB >> 24646078

Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells.

Lovisa Lundholm1, Petra Hååg, Therese Juntti, Rolf Lewensohn, Kristina Viktorsson.   

Abstract

PURPOSE: We aimed to analyze the activation status of commonly deregulated receptor tyrosine kinases (RTK) in human non-small cell lung cancer (NSCLC) tumor initiating cells (TIC) previously demonstrated to be refractory to ionizing radiation and chemotherapy.
MATERIALS AND METHODS: Phosphorylated RTK and important signaling nodes were assayed using PathScan RTK Signaling Antibody Array Kit in NSCLC TIC and bulk cells 4 h post-irradiation (IR) and validated by Western blot. The effect of mitogen- activated protein kinase kinase (MEK) inhibition combined with IR was analyzed using clonogenic assay.
RESULTS: H125 TIC displayed decreased basal phosphorylation of insulin-like growth factor 1 receptor (IGF-1R) and signal transducer and activator of transcription 1 (STAT1) (Tyr701) as compared to bulk cells. Total IGF-1R levels were significantly lower in NSCLC TIC as compared to bulk cells. A higher degree of extracellular signal-regulated kinase (ERK) phosphorylation was evident in TIC and concordantly MEK inhibition reduced TIC viability. Moreover, MEK inhibition also decreased clonogenicity upon IR suggesting that MEK and downstream signaling impart on TIC radiation response.
CONCLUSIONS: We demonstrate reduced basal phosphorylation of several signaling pathways including lower total IGF-1R levels in NSCLC TIC which is of potential concern for RTK inhibitor use. Importantly, MEK inhibition decreased cell viability of NSCLC TIC alone or in combination with IR.

Entities:  

Keywords:  ERK; IGF-1R; MEK; Tumor initiating cell; cancer stem cell; non-small cell lung cancer

Mesh:

Substances:

Year:  2014        PMID: 24646078     DOI: 10.3109/09553002.2014.905725

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  6 in total

1.  Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway.

Authors:  Wei Ma; Yanhong Kang; Lanlan Ning; Jie Tan; Hanping Wang; Yi Ying
Journal:  Exp Ther Med       Date:  2017-07-28       Impact factor: 2.447

2.  Freeware tool for analysing numbers and sizes of cell colonies.

Authors:  Beata Brzozowska; Maciej Gałecki; Adrianna Tartas; Józef Ginter; Urszula Kaźmierczak; Lovisa Lundholm
Journal:  Radiat Environ Biophys       Date:  2019-01-23       Impact factor: 1.925

3.  Impact of ATM and DNA-PK Inhibition on Gene Expression and Individual Response of Human Lymphocytes to Mixed Beams of Alpha Particles and X-Rays.

Authors:  Lei Cheng; Beata Brzozowska-Wardecka; Halina Lisowska; Andrzej Wojcik; Lovisa Lundholm
Journal:  Cancers (Basel)       Date:  2019-12-13       Impact factor: 6.639

4.  Alpha Radiation as a Way to Target Heterochromatic and Gamma Radiation-Exposed Breast Cancer Cells.

Authors:  Maja Svetličič; Anton Bomhard; Christoph Sterr; Fabian Brückner; Magdalena Płódowska; Halina Lisowska; Lovisa Lundholm
Journal:  Cells       Date:  2020-05-08       Impact factor: 6.600

5.  Biological effectiveness of very high gamma dose rate and its implication for radiological protection.

Authors:  Dante Olofsson; Lei Cheng; Rubén Barrios Fernández; Magdalena Płódowska; Milagrosa López Riego; Pamela Akuwudike; Halina Lisowska; Lovisa Lundholm; Andrzej Wojcik
Journal:  Radiat Environ Biophys       Date:  2020-06-01       Impact factor: 1.925

6.  Simultaneous induction of dispersed and clustered DNA lesions compromises DNA damage response in human peripheral blood lymphocytes.

Authors:  Lei Cheng; Beata Brzozowska; Alice Sollazzo; Lovisa Lundholm; Halina Lisowska; Siamak Haghdoost; Andrzej Wojcik
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.